Alström syndrome is associated with short stature and reduced GH reserve

Clinical Endocrinology

Volumn 79, Issue 4, 2013, Pages 529-536

  Romano, S ^a   Maffei, P ^a   Bettini, V ^a   Milan, G ^a   Favaretto, F ^a   Gardiman, M ^a   Marshall, J D ^b   Greggio, N A ^a   Pozzan, G B ^c   Collin, G B ^b   Naggert, J K ^b   Bronson, R ^d   Vettor, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b JACKSON LABORATORY   (United States)

^c OSPEDALE DELL'ANGELO   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; LIOTHYRONINE; LUTEINIZING HORMONE; TESTOSTERONE;

ADOLESCENT; ADULT; AGE; ALSTROM SYNDROME; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFANT; LONGITUDINAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETERS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SHORT STATURE;

ADOLESCENT; ADULT; ALSTROM SYNDROME; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DIENCEPHALON; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INFANT; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PITUITARY GLAND; PROTEINS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84883500505     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12180     Document Type: Article

References (35)

1. Marshall, J.D., Ludman, M.D., Shea, S.E., et al,. (1997) Genealogy, natural history, and phenotype features of Alström syndrome in a large Acadian kindred and three additional families. American Journal of Medical Genetics, 73, 150-161.
2. Marshall, J.D., Bronson, R.T., Collin, G.B., et al,. (2005) New Alström syndrome phenotypes based on the evaluation of 182 cases. Archives of Internal Medicine, 165, 675-683.
3. Marshall, J.D., Beck, S., Maffei, P., et al,. (2007) Alström syndrome. European Journal of Human Genetics, 15, 1193-1202.
4. Marshall, J.D., Maffei, P., Collin, G.B., et al,. (2011) Alström syndrome: genetics and clinical overview. Current Genomics, 12, 225-235.
5. Collin, G.B., Marshall, J.D., Ikeda, A., et al,. (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nature Genetics, 31, 74-78.
6. Hearn, T., Renforth, G.L., Spalluto, C., et al,. (2002) Mutations of ALMS1, a large gene with tandem repeat encoding 47 amino acids, causes Alström syndrome. Nature Genetics, 31, 79-83.
7. Andersen, J.S., Wilkinson, C.J., Mayor, T., et al,. (2003) Proteomic characterization of the human centrosome by protein correlation profiling. Nature, 426, 570-574.
8. Collin, G.B., Cyr, E., Bronson, R., et al,. (2005) Alms1-disrupted mice recapitulate human Alström syndrome. Human Molecular Genetics, 14, 2323-2333.
9. Hearn, T., Spalluto, C., Phillips, V.J., et al,. (2005) Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes, 54, 1581-1587.
10. Li, G., Vega, R., Nelms, K., et al,. (2007) A role for Alström syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genetics 3: e8. 0009-0020.
11. Badano, J.L., Mitsuma, N., Beales, P.L., et al,. (2006) The ciliopathies: an emerging class of human genetic disorders. Annual Review of Genomics and Human Genetics, 22, 125-148.
12. Blacque, O.E., &, Leroux, M.R., (2006) Bardet-Biedl syndrome: an emerging pathomechanism of intracellular transport. Cellular and Molecular Life Sciences, 63, 2145-2161.
13. Alter, C.A., &, Moshang, T.J., (1993) Growth hormone deficiency in two siblings with Alström syndrome. American Journal of Diseases of Children, 147, 97-99.
14. Zumsteg, U., Muller, P.Y., &, Miserez, A.R., (2000) Alstrom syndrome: confirmation of linkage to chromosome 2p12-13 and phenotypic heterogeneity in three affected sibs. Journal of Medical Genetics, 37, E8.
15. Tai, T.S., Lin, S.Y., &, Sheu, W.H., (2003) Metabolic effects of growth hormone therapy in an Alström syndrome patient. Hormone Research, 60, 297-301.
16. Maffei, P., Boschetti, M., Marshall, J.D., et al,. (2007) Characterization of the IGF system in 15 patients with Alström syndrome. Clinical Endocrinology, 66, 269-275.
17. Ho, K.K., Deficiency Consensus Workshop Participants., (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology, 157, 695-700.
18. Ghigo, E., Bellone, J., Aimaretti, G., et al,. (1996) Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. Journal of Clinical Endocrinology and Metabolism, 81, 3323-3327.
19. Hoeck, H.C., Vestergaard, P., Jakobsen, P.E., et al,. (1995) Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. European Journal of Endocrinology, 133, 305-312.
20. Jones, S.L., Trainer, P.J., Perry, L., et al,. (1994) An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clinical Endocrinology, 41, 123-128.
21. Vestergaard, P., Hoeck, H.C., Jakobsen, P.E., et al,. (1997) Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Hormone and Metabolic Research, 29, 106-110.
22. Greulich, W.W., &, Pyle, S.I., (1959) Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford University Press, Stanford, CA.
23. Arsov, T., Silva, D.G., O'Bryan, M.K., et al,. (2006) Fat aussie. A new Alström syndrome mouse. Molecular Endocrinology, 20, 1610-1622.
24. Russell-Eggitt, I.M., Clayton, P.T., Coffey, R., et al,. (1998) Alstrom syndrome. Reoport of 22 cases and literature review. Ophthalmology, 105, 1274-1280.
25. Catrinoiu, D., Mihai, C.M., Tuta, L., et al,. (2009) Rare case of Alstrom syndrome with empty sella and interfamilial presence of Bardet-Biedl phenotype. Journal of medicine and life, 2, 98-103.
26. Growth Hormone Research Society. (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Journal of Clinical Endocrinology and Metabolism, 85, 3990-3993.
27. Shalet, S.M., Toogood, A., Rahim, A., et al,. (1998) The diagnosis of growth hormone deficiency in children and adults. Endocrine Reviews, 19, 203-223.
28. Hoffman, D.M., O'Sullivan, A.J., Baxter, R.C., et al,. (1994) Diagnosis of growth hormone deficiency in adults. Lancet, 343, 1064-1068.
29. Reutens, A.T., Hoffman, D.M., Leung, K., et al,. (1995) Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism, 80, 480-485.
30. Ghigo, E., Aimaretti, G., Gianotti, L., et al,. (1996) New approach to the diagnosis of growth hormone deficiency in adults. European Journal of Endocrinology, 134, 352-356.
31. Bettini, V., Maffei, P., Pagano, C., et al,. (2012) The progression from obesity to type 2 diabetes in Alstrom syndrome. Pediatr Diabetes, 13, 59-67.
32. Thissen, J.P., Ketelslegers, J.M., &, Underwood, L.E., (1994) Nutritional regulation of the insulin-like growth factors. Endocrine Reviews, 15, 80-101.
33. Soliman, A.T., Rajab, A., AlSalmi, I., et al,. (1996) Empty sellae, impaired testosterone secretion, and defective hypothalamic-pituitary growth and gonadal axes in children with Bardet-Biedl syndrome. Metabolism, 45, 1230-1234.
34. Gerdes, J.M., Davis, E.E., &, Katsanis, N., (2009) The vertebrate primary cilium in development, homeostasis, and disease. Cell, 137, 32-45.
35. Zulato, E., Favaretto, F., Veronese, C., et al,. (2011) ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS ONE, 6, e19081.